Newswise — A recent study published in Muscle & Nerve explored the prevalence of male sexual dysfunction in type 1 diabetes. Written by Ana Calzada-Reyes of Havana, Cuba, the study investigated the “prevalence of sexual dysfunction in a sample of males with type 1 diabetes.”

“Sexual dysfunction is a common complication of diabetes that adversely affects patients’ quality of life,” Calzada-Reyes wrote. “Somatic and autonomic neuropathy are common complications of diabetes mellitus.”

The abstract for this study was published in the 2019 American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) Abstract Guide, which was presented at the 2019 AANEM Annual Meeting in Austin, Texas this October.

Nervous structures of the pelvic floor were investigated in 62 type 1 diabetes patients, specifically the bulbocavernosus reflex and somatosensory evoked potentials of the pudendal nerve were investigated, which participate in sexual function.

Calzada-Reyes reported that 71 percent of patients had abnormalities and 21 percent had clinical manifestations. Needle EMG showed abnormality in 92 percent of patients.

“Sexual dysfunction is a common complication in diabetic patients. The combination of anamnesis and an ad hoc neurophysiological protocol showed its high prevalence and provided a more accurate prognosis,” she wrote in her conclusion.

To view the 2019 AANEM Abstract Guide, visit

About American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM)

Based in Rochester, Minnesota, the American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) is the premier nonprofit membership association dedicated to the advancement of neuromuscular (NM), musculoskeletal and electrodiagnostic (EDX) medicine. The organization and its members work to improve the quality of patient care and advance the science of NM diseases and EDX medicine by serving physicians and allied health professionals who care for those with muscle and nerve disorders.

For more information about AANEM, visit or find us on Facebook, Twitter, LinkedIn and YouTube.